Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rewalk Robotics (LFWD)
NASDAQ:LFWD
Holding LFWD?
Track your performance easily
LFWD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.41 - $7.84
Previous CloseN/A
Volume483.00K
Average Volume (3M)488.74K
Market Cap
$19.23M
Enterprise Value$18.88M
Total Cash (Recent Filing)$23.68M
Total Debt (Recent Filing)$10.52M
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Feb 20, 2025EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.24
Shares Outstanding10,626,799
10 Day Avg. Volume1,189,262
30 Day Avg. Volume488,737
Standard Deviation0.28
R-Squared0.15
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue0.75
Enterprise Value/Gross Profit4.24
Enterprise Value/Ebitda-1.17
Forecast
1Y Price Target
$9.50Price Target Upside479.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Rewalk Robotics News
PremiumCompany Announcements
Rewalk Robotics Welcomes Robert J. Marshall Jr. to BoardBulls Say, Bears Say
Bulls Say
Cost SavingsThe company initiated the closing of two U.S. facilities with the full integration of the AlterG business segment, for a projected savings of approximately $3M.
Market OpportunityThe addressable market is large enough, and the company is able to reach patients with their solution.
Revenue GrowthLifeward reported $6.1M in revenue for 3Q24, representing a 39% YoY growth from $4.4M in 3Q23.
Bears Say
Cash FlowWith the Medicare Part B processing timeline sitting at approximately 150 days for ReWalk cases submitted, investors are likely to question whether the company's present cash is sufficient to reach breakeven if these timelines do not accelerate.
EarningsQ3 results and 2024 revenue guidance both fell short of analyst expectations.
Financial PerformanceThe company reported total revenues of $6.1M, lower than the consensus estimate of $8.4M, and a net loss of $0.35 per share, higher than the consensus estimated net loss of $0.32 per share.
---
Ownership Overview
11.18% Insiders
0.20% Mutual Funds
4.00% Other Institutional Investors
84.62% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LFWD FAQ
What was Rewalk Robotics’s price range in the past 12 months?
Rewalk Robotics lowest stock price was $1.41 and its highest was $7.84 in the past 12 months.
What is Rewalk Robotics’s market cap?
Rewalk Robotics’s market cap is $19.23M.
When is Rewalk Robotics’s upcoming earnings report date?
Rewalk Robotics’s upcoming earnings report date is Feb 20, 2025 which is in 33 days.
How were Rewalk Robotics’s earnings last quarter?
Rewalk Robotics released its earnings results on Nov 12, 2024. The company reported -$0.35 earnings per share for the quarter, missing the consensus estimate of -$0.315 by -$0.035.
Is Rewalk Robotics overvalued?
According to Wall Street analysts Rewalk Robotics’s price is currently Undervalued.
Does Rewalk Robotics pay dividends?
Rewalk Robotics does not currently pay dividends.
What is Rewalk Robotics’s EPS estimate?
Rewalk Robotics’s EPS estimate is -0.29.
How many shares outstanding does Rewalk Robotics have?
Rewalk Robotics has 10,626,799 shares outstanding.
What happened to Rewalk Robotics’s price movement after its last earnings report?
Rewalk Robotics reported an EPS of -$0.35 in its last earnings report, missing expectations of -$0.315. Following the earnings report the stock price went up 0.844%.
Which hedge fund is a major shareholder of Rewalk Robotics?
Currently, no hedge funds are holding shares in LFWD
---
Company Description
Rewalk Robotics
ReWalk Robotics Ltd. engages in the design, development and marketing of wearable robotic exoskeletons. Its exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. The firm's systems include ReWalk Rehabilitation and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.
---
LFWD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While the company saw a notable increase in revenue and improvement in gross profit, challenges remain with the AlterG business underperforming and delays in Medicare payments impacting sales. The company's efforts to expand its U.S. pipeline and control operating expenses are encouraging, but the challenges with capital expenditures and payment processing times indicate areas that need attention.Read More>---
LFWD Stock 12 Month Forecast
Average Price Target
$9.50
▲(479.27% Upside)
Technical Analysis
BioSig Technologies
―
Myomo
―
Helius Medical Technologies
―
EKSO BIONICS
―
Smith & Nephew Snats
―
Best Analysts Covering LFWD
1 Year
1 Year Success Rate
2/15 ratings generated profit
1 Year Average Return
-31.70%
reiterated a buy rating 2 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 13.33% of your transactions generating a profit, with an average return of -31.70% per trade.
---